Evaluation of Adherence to Venous Thromboembolism Prophylaxis Guidelines Among US Adults After Pancreatic Cancer Surgery

Lauren M Perry; Sarah B Bateni; Ryan P Merkow; Robert J Canter; Richard J Bold; Julie Hallet; Sepideh Gholami

doi:10.1001/jamasurg.2022.2590

Evaluation of Adherence to Venous Thromboembolism Prophylaxis Guidelines Among US Adults After Pancreatic Cancer Surgery

JAMA Surg. 2022 Sep 1;157(9):850-852. doi: 10.1001/jamasurg.2022.2590.

Authors

Lauren M Perry¹, Sarah B Bateni², Ryan P Merkow³, Robert J Canter¹, Richard J Bold¹, Julie Hallet², Sepideh Gholami¹

Affiliations

¹ Division of Surgical Oncology, Department of Surgery, University of California Davis, Sacramento.
² Department of Surgery, Division of Surgical Oncology, Odette Cancer Centre-Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
³ Northwestern Institute for Comparative Effectiveness Research in Oncology, Surgical Outcomes and Quality Improvement Center and Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Abstract

This cohort study evaluates postoperative adherence to venous thromboembolism prophylaxis guidelines among US adults with pancreatic cancer using a national population sample drawn from Surveillance, Epidemiology, and End Results–Medicare data.

MeSH terms

Adult
Anticoagulants / therapeutic use
Guideline Adherence
Humans
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / surgery
Risk Factors
Venous Thromboembolism* / etiology
Venous Thromboembolism* / prevention & control

Substances

Anticoagulants